Gilbert Omenn

Gilbert Omenn

Directeur/Bestuurslid bij GALECTIN THERAPEUTICS INC.

Vermogen: 461 353 $ op 30-09-2026

85 jaar
Commercial Services
Health Technology
Consumer Services

Profiel

Dr. Gilbert S.
Omenn
is an Independent Director at Amesite, Inc., an Independent Director at Galectin Therapeutics, Inc., a Professor at University of Michigan, a Member at American Academy of Arts & Sciences, a Member at Association of American Physicians, a Member at National Academy of Medicine (United States), a Member-Community Preventive Services Task Force of Centers for Disease Control & Prevention and a Vice President at Human Proteome Organization.
He is on the Board of Directors at Amesite, Inc., Galectin Therapeutics, Inc., Armune BioScience, Inc., Life Sciences Society, MedsynBio LLCuu, Oncofusion Therapeutics, Inc., Phenomics Health, Inc., Population Services International, Salzburg Global Seminar, Inc., The Center for Public Integrity, The Hastings Center and The CNA Corp.
Dr. Omenn was previously employed as an Independent Director by Angion Biomedica Corp., a Council Member by National Academy of Medicine (United States), an Independent Director by Esperion Therapeutics, Inc., a Member-Scientific Management Review by National Institutes of Health, a Chief Executive Officer by University of Michigan Health System, a Chief Executive Officer by University of Miami Health System, an Independent Director by Amgen, Inc., a Professor by University of Washington, an Associate Director by Office of Management & Budget, an Associate Director by Office of Science & Technology Policy, a President by American Association for the Advancement of Science, a Member by American College of Physicians, Inc. /Old/, an Advisor by Arboretum Ventures LLC, a Member by Fred Hutchinson Cancer Research Center, an Affiliate Faculty by Institute for Systems Biology, and a Chairman by tranSMART Foundation.
He also served on the board at Amesite, Inc. /Old/, Etubics Corp., Trukera Medical, Rohm & Haas Co., Fred Hutchinson Cancer Research Center, Unitunited Way Foundation and US Civilian Research & Development Foundation.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
28-02-2026 82.240 ( 0,08% ) 319 091 $ 30-09-2026
30-09-2026 143.699 ( 2,19% ) 142 262 $ 30-09-2026

Actieve functies van Gilbert Omenn

BedrijvenFunctieBegin
GALECTIN THERAPEUTICS INC. Directeur/Bestuurslid 23-09-2014
AMESITE INC. Directeur/Bestuurslid 01-03-2020
Directeur/Bestuurslid -
Corporate Officer/Principal -
Directeur/Bestuurslid -
MedsynBio LLCuu
Directeur/Bestuurslid -
Directeur/Bestuurslid 20-05-2011
Directeur/Bestuurslid -
Directeur/Bestuurslid 18-04-2011
░░░░░░░░ ░░░░░░░ ░░ ░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -

Eerdere bekende functies van Gilbert Omenn

BedrijvenFunctieEinde
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░ ░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Gilbert Omenn in detail bekijken

Opleiding van Gilbert Omenn

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

89

Eerstegraads connecties

41

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit41

Health Technology

Process Industries

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Consumer Services

Consumer Services

Consumer Services

Government

Government

Commercial Services

Consumer Services

Commercial Services

Government

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Human Proteome Organization

Commercial Services

Health Technology

Commercial Services

Commercial Services

Consumer Services

Commercial Services

Miscellaneous

Commercial Services

Life Sciences Society

Health Services

Health Technology

Commercial Services

Finance

Technology Services

Technology Services

Office of Management & Budget

MedsynBio LLCuu

Finance

  1. Beurs
  2. Insiders
  3. Gilbert Omenn